Conditions: Diabetes Mellitus, Type 2
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 24
Healthy volunteers: no

Brief summary:
the pharmacokinetics, pharmacodynamics and safety and tolerability of single and multiple oral doses of BI 10773 at low dose once daily (q.d.) and high dose q.d. administered to Chinese female and male patients with type 2 diabetes will be investigated.

Detailed description:

Arms:
arm 1: patient to receive a tablet containing low dose BI10773 Per Os(p.o.) plus one placebo arm 2: patient to receive two placebos arm 3: patient to receive a tablet containing high dose BI10773 Per Os(p.o.) plus one placebo

Interventions: intervention 1: BI10773 intervention 2: Placebo intervention 3: Placebo intervention 4: Placebo intervention 5: BI10773
Intervention descriptions: intervention 1: patient to receive a tablet containing high dose BI10773 p.o. plus one placebo intervention 2: patient to receive two placebos intervention 3: patient to receive two placebos intervention 4: patient to receive two placebos intervention 5: patient to receive a tablet containing low dose BI10773 p.o. plus one placebo

Protocol document: